UNSPSC 85581209: Supplement buccal mucosa with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement buccal mucosa with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0CU437Z

UNSPSC 85581209 Supplement buccal mucosa with autologous tissue substitute, percutaneous approach is a Commodity code that does not align with the recent state and local contract opportunities posted under it. The code describes a specific surgical procedure involving tissue grafting to the inside of the mouth, yet the recent solicitations tagged to this code cover independent medical evaluation services, pharmacy benefit management, occupational medical surveillance, specialty surgical networks through centers of excellence, temporary health professional staffing, and youth detention healthcare services — none of which involve buccal mucosa procedures or autologous tissue supplementation. The mismatch suggests either a data classification error in the source system or a systematic misalignment between the UNSPSC taxonomy and how the purchasing jurisdictions have tagged these healthcare management and staffing opportunities.

The recent activity under this code shows no relevant procurement activity for the procedure itself. State and local buyers appear to be using the code incorrectly, tagging general healthcare administration and staffing contracts that fall outside the clinical scope of autologous buccal tissue grafting. Without evidence of actual buccal mucosa procedure solicitations in the recent state and local market, this code presents no clear procurement opportunity for vendors in this specialized surgical subspecialty.